GT Medical Technologies Announces GammaTile Improves Survival and Reduces Recurrence in Brain Metastases
TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...
Boston, USA | May 1, 2026 Zeta Surgical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for...
Solana Beach, California | January 22, 2026 ClearPoint Neuro has announced the successful EU Medical Device Regulation (EU MDR)...
Dateline: November 17, 2025 — Lisle, IllinoisHubly Surgical Inc. announced that the Auto-Stop Drill, its cordless surgical tool equipped...
LISLE, Ill., Nov. 12, 2025—Hubly Surgical announced that its Hubly Auto-Stop Drill has received FDA 510(k) clearance expanding the...
